Fujian Luyan
Latest round
- Series B
Last raised
- Jun 2010
Total raised
- $22M
Investors
- 2
About Fujian Luyan
Founded in 1992, Fujian Luyan is headquartered in Xiamen, China, and specializes in pharmaceutical development.73 million., Ltd. focuses on developing and manufacturing a wide range of pharmaceutical products, including therapeutic agents for chronic illnesses, infectious diseases, and pain management.65 per share on the Shenzhen Stock Exchange, Fujian Luyan is focused on expanding its product line and entering new markets. The company is developing new pharmaceutical products aimed at further addressing chronic and infectious diseases, with plans to enhance its presence in markets throughout Asia and Europe by 2025.
Who invested in Fujian Luyan
2 investors across 2 rounds
See all investors in Fujian Luyan
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Fujian Luyan
Who invested in Fujian Luyan?
Fujian Luyan has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fujian Luyan raised?
Fujian Luyan has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Fujian Luyan last raise money?
Fujian Luyan's most recent round on record is a Series B, in Jun 2010.
What does Fujian Luyan do?
Founded in 1992, Fujian Luyan is headquartered in Xiamen, China, and specializes in pharmaceutical development.
Where is Fujian Luyan headquartered?
Fujian Luyan is headquartered in Xiamen, China.
Which VCs invest in companies like Fujian Luyan?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Fujian Luyan's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Fujian Luyan? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.